GO:0022627 | cytosolic small ribosomal subunit | 1.14e-22 | 1.65e-18 | 7.765 | 10 | 20 | 39 |
GO:0019058 | viral life cycle | 6.03e-20 | 8.70e-16 | 6.343 | 11 | 23 | 115 |
GO:0019083 | viral transcription | 3.31e-19 | 4.77e-15 | 6.711 | 10 | 20 | 81 |
GO:0006415 | translational termination | 7.03e-19 | 1.01e-14 | 6.608 | 10 | 20 | 87 |
GO:0006414 | translational elongation | 1.42e-18 | 2.04e-14 | 6.511 | 10 | 20 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 4.55e-18 | 6.56e-14 | 6.350 | 10 | 20 | 104 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.18e-17 | 1.70e-13 | 6.218 | 10 | 20 | 114 |
GO:0006413 | translational initiation | 4.97e-17 | 7.17e-13 | 6.017 | 10 | 21 | 131 |
GO:0003735 | structural constituent of ribosome | 7.88e-17 | 1.14e-12 | 5.953 | 10 | 22 | 137 |
GO:0016071 | mRNA metabolic process | 1.13e-14 | 1.63e-10 | 5.250 | 10 | 25 | 223 |
GO:0006412 | translation | 1.54e-14 | 2.23e-10 | 5.205 | 10 | 23 | 230 |
GO:0016070 | RNA metabolic process | 3.17e-14 | 4.57e-10 | 5.102 | 10 | 25 | 247 |
GO:0005829 | cytosol | 1.07e-13 | 1.54e-09 | 2.531 | 17 | 61 | 2496 |
GO:0016032 | viral process | 1.64e-12 | 2.36e-08 | 4.127 | 11 | 33 | 534 |
GO:0015935 | small ribosomal subunit | 7.31e-12 | 1.05e-07 | 7.963 | 5 | 9 | 17 |
GO:0044267 | cellular protein metabolic process | 2.12e-11 | 3.05e-07 | 4.162 | 10 | 23 | 474 |
GO:0016020 | membrane | 3.93e-11 | 5.66e-07 | 2.821 | 14 | 41 | 1681 |
GO:0010467 | gene expression | 6.25e-10 | 9.01e-06 | 3.665 | 10 | 29 | 669 |
GO:0030126 | COPI vesicle coat | 6.50e-10 | 9.37e-06 | 8.144 | 4 | 7 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 9.38e-10 | 1.35e-05 | 8.028 | 4 | 8 | 13 |
GO:0044822 | poly(A) RNA binding | 2.53e-09 | 3.65e-05 | 3.144 | 11 | 32 | 1056 |
GO:0061024 | membrane organization | 1.05e-08 | 1.52e-04 | 5.134 | 6 | 12 | 145 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.65e-08 | 2.37e-04 | 7.085 | 4 | 8 | 25 |
GO:0005925 | focal adhesion | 1.00e-07 | 1.44e-03 | 4.020 | 7 | 19 | 366 |
GO:0030529 | ribonucleoprotein complex | 1.48e-07 | 2.14e-03 | 5.243 | 5 | 7 | 112 |
GO:0005840 | ribosome | 5.39e-07 | 7.77e-03 | 5.871 | 4 | 8 | 58 |
GO:0070062 | extracellular vesicular exosome | 1.19e-06 | 1.72e-02 | 2.085 | 12 | 40 | 2400 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.07e-06 | 2.98e-02 | 6.854 | 3 | 3 | 22 |
GO:0019843 | rRNA binding | 3.91e-06 | 5.64e-02 | 6.559 | 3 | 4 | 27 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.30e-05 | 1.88e-01 | 8.407 | 2 | 3 | 5 |
GO:0033119 | negative regulation of RNA splicing | 1.30e-05 | 1.88e-01 | 8.407 | 2 | 2 | 5 |
GO:0006886 | intracellular protein transport | 4.02e-05 | 5.80e-01 | 4.311 | 4 | 7 | 171 |
GO:0042274 | ribosomal small subunit biogenesis | 8.57e-05 | 1.00e+00 | 7.144 | 2 | 6 | 12 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.76e-04 | 1.00e+00 | 6.641 | 2 | 4 | 17 |
GO:0005844 | polysome | 3.26e-04 | 1.00e+00 | 6.205 | 2 | 2 | 23 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 8.05e-04 | 1.00e+00 | 5.559 | 2 | 3 | 36 |
GO:0022605 | oogenesis stage | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0004347 | glucose-6-phosphate isomerase activity | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0019242 | methylglyoxal biosynthetic process | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0016866 | intramolecular transferase activity | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0005730 | nucleolus | 1.68e-03 | 1.00e+00 | 1.856 | 7 | 24 | 1641 |
GO:0016197 | endosomal transport | 2.01e-03 | 1.00e+00 | 4.896 | 2 | 3 | 57 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0046185 | aldehyde catabolic process | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0003729 | mRNA binding | 3.18e-03 | 1.00e+00 | 4.559 | 2 | 2 | 72 |
GO:0051683 | establishment of Golgi localization | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 2 | 3 |
GO:0034191 | apolipoprotein A-I receptor binding | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0005737 | cytoplasm | 4.36e-03 | 1.00e+00 | 1.171 | 10 | 43 | 3767 |
GO:0048664 | neuron fate determination | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0072384 | organelle transport along microtubule | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 2 | 4 |
GO:0006364 | rRNA processing | 5.36e-03 | 1.00e+00 | 4.174 | 2 | 7 | 94 |
GO:0036336 | dendritic cell migration | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:1902188 | positive regulation of viral release from host cell | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0007097 | nuclear migration | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0002181 | cytoplasmic translation | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 2 | 6 |
GO:0003334 | keratinocyte development | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0045182 | translation regulator activity | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 2 | 6 |
GO:0060789 | hair follicle placode formation | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0048029 | monosaccharide binding | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0006924 | activation-induced cell death of T cells | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0043497 | regulation of protein heterodimerization activity | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0050792 | regulation of viral process | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 7 |
GO:0051156 | glucose 6-phosphate metabolic process | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 7 |
GO:0000028 | ribosomal small subunit assembly | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 3 | 7 |
GO:0034101 | erythrocyte homeostasis | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 7 |
GO:0051489 | regulation of filopodium assembly | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 7 |
GO:0006006 | glucose metabolic process | 8.33e-03 | 1.00e+00 | 3.846 | 2 | 3 | 118 |
GO:0039702 | viral budding via host ESCRT complex | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 8 |
GO:0090136 | epithelial cell-cell adhesion | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 9 |
GO:0007599 | hemostasis | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 9 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 2 | 10 |
GO:0060047 | heart contraction | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 10 |
GO:0043066 | negative regulation of apoptotic process | 1.26e-02 | 1.00e+00 | 2.586 | 3 | 13 | 424 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.30e-02 | 1.00e+00 | 3.509 | 2 | 9 | 149 |
GO:0005198 | structural molecule activity | 1.32e-02 | 1.00e+00 | 3.500 | 2 | 6 | 150 |
GO:1903543 | positive regulation of exosomal secretion | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 12 |
GO:0019082 | viral protein processing | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 2 | 12 |
GO:0043005 | neuron projection | 1.44e-02 | 1.00e+00 | 3.434 | 2 | 6 | 157 |
GO:0031929 | TOR signaling | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 13 |
GO:0032479 | regulation of type I interferon production | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 2 | 13 |
GO:0031333 | negative regulation of protein complex assembly | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 14 |
GO:0030131 | clathrin adaptor complex | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 2 | 14 |
GO:0048821 | erythrocyte development | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 1 | 15 |
GO:0031369 | translation initiation factor binding | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 2 | 15 |
GO:0042176 | regulation of protein catabolic process | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 3 | 16 |
GO:0075733 | intracellular transport of virus | 1.99e-02 | 1.00e+00 | 5.641 | 1 | 3 | 17 |
GO:0030742 | GTP-dependent protein binding | 1.99e-02 | 1.00e+00 | 5.641 | 1 | 1 | 17 |
GO:0019068 | virion assembly | 1.99e-02 | 1.00e+00 | 5.641 | 1 | 2 | 17 |
GO:0090316 | positive regulation of intracellular protein transport | 1.99e-02 | 1.00e+00 | 5.641 | 1 | 1 | 17 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 2.04e-02 | 1.00e+00 | 3.166 | 2 | 4 | 189 |
GO:0007088 | regulation of mitosis | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 18 |
GO:0046847 | filopodium assembly | 2.22e-02 | 1.00e+00 | 5.481 | 1 | 1 | 19 |
GO:0007369 | gastrulation | 2.22e-02 | 1.00e+00 | 5.481 | 1 | 1 | 19 |
GO:0043473 | pigmentation | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 20 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 2.45e-02 | 1.00e+00 | 5.336 | 1 | 1 | 21 |
GO:0031424 | keratinization | 2.56e-02 | 1.00e+00 | 5.269 | 1 | 1 | 22 |
GO:0007220 | Notch receptor processing | 2.56e-02 | 1.00e+00 | 5.269 | 1 | 2 | 22 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 1 | 23 |
GO:0002040 | sprouting angiogenesis | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 1 | 23 |
GO:0007163 | establishment or maintenance of cell polarity | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 1 | 24 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 2 | 25 |
GO:0005978 | glycogen biosynthetic process | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 2 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 2 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 2 | 26 |
GO:0045859 | regulation of protein kinase activity | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 1 | 26 |
GO:0051149 | positive regulation of muscle cell differentiation | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 1 | 27 |
GO:0032467 | positive regulation of cytokinesis | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 1 | 27 |
GO:0045184 | establishment of protein localization | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 2 | 27 |
GO:0031069 | hair follicle morphogenesis | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 1 | 27 |
GO:0072686 | mitotic spindle | 3.37e-02 | 1.00e+00 | 4.871 | 1 | 1 | 29 |
GO:0031647 | regulation of protein stability | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 1 | 30 |
GO:0005975 | carbohydrate metabolic process | 3.51e-02 | 1.00e+00 | 2.746 | 2 | 3 | 253 |
GO:0001890 | placenta development | 3.59e-02 | 1.00e+00 | 4.774 | 1 | 1 | 31 |
GO:0007093 | mitotic cell cycle checkpoint | 3.59e-02 | 1.00e+00 | 4.774 | 1 | 1 | 31 |
GO:0032480 | negative regulation of type I interferon production | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 2 | 32 |
GO:0033077 | T cell differentiation in thymus | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 33 |
GO:0043065 | positive regulation of apoptotic process | 3.89e-02 | 1.00e+00 | 2.663 | 2 | 6 | 268 |
GO:0007611 | learning or memory | 3.93e-02 | 1.00e+00 | 4.641 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 3.93e-02 | 1.00e+00 | 4.641 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 2 | 36 |
GO:0045740 | positive regulation of DNA replication | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 1 | 36 |
GO:0006096 | glycolytic process | 4.39e-02 | 1.00e+00 | 4.481 | 1 | 1 | 38 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 4.73e-02 | 1.00e+00 | 4.371 | 1 | 3 | 41 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 4.95e-02 | 1.00e+00 | 4.302 | 1 | 2 | 43 |
GO:0006094 | gluconeogenesis | 4.95e-02 | 1.00e+00 | 4.302 | 1 | 1 | 43 |
GO:0021762 | substantia nigra development | 5.06e-02 | 1.00e+00 | 4.269 | 1 | 1 | 44 |
GO:0034613 | cellular protein localization | 5.06e-02 | 1.00e+00 | 4.269 | 1 | 2 | 44 |
GO:0045727 | positive regulation of translation | 5.06e-02 | 1.00e+00 | 4.269 | 1 | 1 | 44 |
GO:0008344 | adult locomotory behavior | 5.06e-02 | 1.00e+00 | 4.269 | 1 | 1 | 44 |
GO:0019901 | protein kinase binding | 5.27e-02 | 1.00e+00 | 2.420 | 2 | 6 | 317 |
GO:0044297 | cell body | 5.29e-02 | 1.00e+00 | 4.205 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 5.29e-02 | 1.00e+00 | 4.205 | 1 | 2 | 46 |
GO:0006959 | humoral immune response | 5.40e-02 | 1.00e+00 | 4.174 | 1 | 1 | 47 |
GO:0007030 | Golgi organization | 5.62e-02 | 1.00e+00 | 4.114 | 1 | 2 | 49 |
GO:0007254 | JNK cascade | 5.62e-02 | 1.00e+00 | 4.114 | 1 | 3 | 49 |
GO:0030175 | filopodium | 5.74e-02 | 1.00e+00 | 4.085 | 1 | 2 | 50 |
GO:0030666 | endocytic vesicle membrane | 6.07e-02 | 1.00e+00 | 4.001 | 1 | 2 | 53 |
GO:0051403 | stress-activated MAPK cascade | 6.18e-02 | 1.00e+00 | 3.974 | 1 | 3 | 54 |
GO:0046330 | positive regulation of JNK cascade | 6.29e-02 | 1.00e+00 | 3.947 | 1 | 1 | 55 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 6.73e-02 | 1.00e+00 | 3.846 | 1 | 1 | 59 |
GO:0032481 | positive regulation of type I interferon production | 6.96e-02 | 1.00e+00 | 3.798 | 1 | 3 | 61 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 6.96e-02 | 1.00e+00 | 3.798 | 1 | 2 | 61 |
GO:0030141 | secretory granule | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 1 | 62 |
GO:0006417 | regulation of translation | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 2 | 62 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 7.18e-02 | 1.00e+00 | 3.751 | 1 | 2 | 63 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 7.29e-02 | 1.00e+00 | 3.729 | 1 | 6 | 64 |
GO:0008284 | positive regulation of cell proliferation | 7.32e-02 | 1.00e+00 | 2.151 | 2 | 7 | 382 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.40e-02 | 1.00e+00 | 3.706 | 1 | 6 | 65 |
GO:0031295 | T cell costimulation | 7.40e-02 | 1.00e+00 | 3.706 | 1 | 3 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 7.40e-02 | 1.00e+00 | 3.706 | 1 | 4 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 7.40e-02 | 1.00e+00 | 3.706 | 1 | 4 | 65 |
GO:0035264 | multicellular organism growth | 7.61e-02 | 1.00e+00 | 3.663 | 1 | 1 | 67 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.94e-02 | 1.00e+00 | 3.599 | 1 | 8 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 8.05e-02 | 1.00e+00 | 3.579 | 1 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 8.05e-02 | 1.00e+00 | 3.579 | 1 | 4 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 4 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 6 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 4 | 73 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 8.38e-02 | 1.00e+00 | 3.519 | 1 | 2 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 8.38e-02 | 1.00e+00 | 3.519 | 1 | 8 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 8.49e-02 | 1.00e+00 | 3.500 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 8.49e-02 | 1.00e+00 | 3.500 | 1 | 6 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 8.59e-02 | 1.00e+00 | 3.481 | 1 | 4 | 76 |
GO:0010629 | negative regulation of gene expression | 8.70e-02 | 1.00e+00 | 3.462 | 1 | 2 | 77 |
GO:0031902 | late endosome membrane | 8.70e-02 | 1.00e+00 | 3.462 | 1 | 2 | 77 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 8.81e-02 | 1.00e+00 | 3.443 | 1 | 4 | 78 |
GO:0034138 | toll-like receptor 3 signaling pathway | 8.92e-02 | 1.00e+00 | 3.425 | 1 | 4 | 79 |
GO:0005179 | hormone activity | 8.92e-02 | 1.00e+00 | 3.425 | 1 | 1 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.92e-02 | 1.00e+00 | 3.425 | 1 | 8 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 9.03e-02 | 1.00e+00 | 3.407 | 1 | 4 | 80 |
GO:0045177 | apical part of cell | 9.13e-02 | 1.00e+00 | 3.389 | 1 | 1 | 81 |
GO:0050852 | T cell receptor signaling pathway | 9.57e-02 | 1.00e+00 | 3.319 | 1 | 2 | 85 |
GO:0042593 | glucose homeostasis | 9.78e-02 | 1.00e+00 | 3.286 | 1 | 1 | 87 |
GO:0000187 | activation of MAPK activity | 1.01e-01 | 1.00e+00 | 3.237 | 1 | 2 | 90 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.03e-01 | 1.00e+00 | 3.205 | 1 | 6 | 92 |
GO:0001649 | osteoblast differentiation | 1.03e-01 | 1.00e+00 | 3.205 | 1 | 3 | 92 |
GO:0071456 | cellular response to hypoxia | 1.03e-01 | 1.00e+00 | 3.205 | 1 | 3 | 92 |
GO:0034142 | toll-like receptor 4 signaling pathway | 1.07e-01 | 1.00e+00 | 3.144 | 1 | 4 | 96 |
GO:0030496 | midbody | 1.20e-01 | 1.00e+00 | 2.974 | 1 | 2 | 108 |
GO:0002224 | toll-like receptor signaling pathway | 1.21e-01 | 1.00e+00 | 2.960 | 1 | 4 | 109 |
GO:0005815 | microtubule organizing center | 1.21e-01 | 1.00e+00 | 2.960 | 1 | 3 | 109 |
GO:0097190 | apoptotic signaling pathway | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 3 | 113 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.27e-01 | 1.00e+00 | 2.883 | 1 | 4 | 115 |
GO:0000209 | protein polyubiquitination | 1.28e-01 | 1.00e+00 | 2.871 | 1 | 7 | 116 |
GO:0043524 | negative regulation of neuron apoptotic process | 1.29e-01 | 1.00e+00 | 2.858 | 1 | 2 | 117 |
GO:0007219 | Notch signaling pathway | 1.32e-01 | 1.00e+00 | 2.822 | 1 | 3 | 120 |
GO:0030036 | actin cytoskeleton organization | 1.36e-01 | 1.00e+00 | 2.786 | 1 | 2 | 123 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.37e-01 | 1.00e+00 | 2.774 | 1 | 3 | 124 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.41e-01 | 1.00e+00 | 2.729 | 1 | 3 | 128 |
GO:0005911 | cell-cell junction | 1.49e-01 | 1.00e+00 | 2.641 | 1 | 2 | 136 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.49e-01 | 1.00e+00 | 2.641 | 1 | 5 | 136 |
GO:0005125 | cytokine activity | 1.51e-01 | 1.00e+00 | 2.620 | 1 | 1 | 138 |
GO:0008083 | growth factor activity | 1.54e-01 | 1.00e+00 | 2.589 | 1 | 1 | 141 |
GO:0045087 | innate immune response | 1.54e-01 | 1.00e+00 | 1.509 | 2 | 8 | 596 |
GO:0008286 | insulin receptor signaling pathway | 1.55e-01 | 1.00e+00 | 2.579 | 1 | 3 | 142 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.58e-01 | 1.00e+00 | 2.549 | 1 | 3 | 145 |
GO:0010628 | positive regulation of gene expression | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 4 | 146 |
GO:0034220 | ion transmembrane transport | 1.62e-01 | 1.00e+00 | 2.509 | 1 | 2 | 149 |
GO:0042981 | regulation of apoptotic process | 1.63e-01 | 1.00e+00 | 2.500 | 1 | 7 | 150 |
GO:0010008 | endosome membrane | 1.64e-01 | 1.00e+00 | 2.490 | 1 | 5 | 151 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.69e-01 | 1.00e+00 | 2.443 | 1 | 3 | 156 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 1.81e-01 | 1.00e+00 | 2.336 | 1 | 3 | 168 |
GO:0019904 | protein domain specific binding | 1.91e-01 | 1.00e+00 | 2.245 | 1 | 3 | 179 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.96e-01 | 1.00e+00 | 2.205 | 1 | 3 | 184 |
GO:0001525 | angiogenesis | 2.03e-01 | 1.00e+00 | 2.151 | 1 | 3 | 191 |
GO:0003924 | GTPase activity | 2.09e-01 | 1.00e+00 | 2.107 | 1 | 7 | 197 |
GO:0006184 | GTP catabolic process | 2.25e-01 | 1.00e+00 | 1.987 | 1 | 7 | 214 |
GO:0019221 | cytokine-mediated signaling pathway | 2.31e-01 | 1.00e+00 | 1.941 | 1 | 2 | 221 |
GO:0007067 | mitotic nuclear division | 2.36e-01 | 1.00e+00 | 1.902 | 1 | 5 | 227 |
GO:0030425 | dendrite | 2.39e-01 | 1.00e+00 | 1.883 | 1 | 2 | 230 |
GO:0043025 | neuronal cell body | 2.53e-01 | 1.00e+00 | 1.792 | 1 | 4 | 245 |
GO:0000166 | nucleotide binding | 2.65e-01 | 1.00e+00 | 1.712 | 1 | 2 | 259 |
GO:0006281 | DNA repair | 2.67e-01 | 1.00e+00 | 1.701 | 1 | 4 | 261 |
GO:0005634 | nucleus | 2.72e-01 | 1.00e+00 | 0.381 | 7 | 43 | 4559 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.74e-01 | 1.00e+00 | 1.657 | 1 | 4 | 269 |
GO:0007264 | small GTPase mediated signal transduction | 2.83e-01 | 1.00e+00 | 1.604 | 1 | 7 | 279 |
GO:0030154 | cell differentiation | 3.01e-01 | 1.00e+00 | 1.495 | 1 | 2 | 301 |
GO:0005525 | GTP binding | 3.09e-01 | 1.00e+00 | 1.452 | 1 | 7 | 310 |
GO:0005615 | extracellular space | 3.13e-01 | 1.00e+00 | 0.826 | 2 | 2 | 957 |
GO:0007275 | multicellular organismal development | 3.14e-01 | 1.00e+00 | 1.425 | 1 | 1 | 316 |
GO:0043231 | intracellular membrane-bounded organelle | 3.16e-01 | 1.00e+00 | 1.416 | 1 | 5 | 318 |
GO:0007411 | axon guidance | 3.16e-01 | 1.00e+00 | 1.411 | 1 | 3 | 319 |
GO:0015031 | protein transport | 3.34e-01 | 1.00e+00 | 1.315 | 1 | 8 | 341 |
GO:0003723 | RNA binding | 3.35e-01 | 1.00e+00 | 1.311 | 1 | 8 | 342 |
GO:0000139 | Golgi membrane | 3.50e-01 | 1.00e+00 | 1.233 | 1 | 6 | 361 |
GO:0000278 | mitotic cell cycle | 3.73e-01 | 1.00e+00 | 1.118 | 1 | 11 | 391 |
GO:0055085 | transmembrane transport | 4.06e-01 | 1.00e+00 | 0.964 | 1 | 3 | 435 |
GO:0005515 | protein binding | 4.17e-01 | 1.00e+00 | 0.172 | 8 | 62 | 6024 |
GO:0007596 | blood coagulation | 4.20e-01 | 1.00e+00 | 0.899 | 1 | 3 | 455 |
GO:0044281 | small molecule metabolic process | 4.24e-01 | 1.00e+00 | 0.487 | 2 | 15 | 1211 |
GO:0042802 | identical protein binding | 4.40e-01 | 1.00e+00 | 0.810 | 1 | 3 | 484 |
GO:0048471 | perinuclear region of cytoplasm | 4.53e-01 | 1.00e+00 | 0.757 | 1 | 7 | 502 |
GO:0006915 | apoptotic process | 4.87e-01 | 1.00e+00 | 0.612 | 1 | 9 | 555 |
GO:0005783 | endoplasmic reticulum | 4.88e-01 | 1.00e+00 | 0.610 | 1 | 3 | 556 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.96e-01 | 1.00e+00 | 0.574 | 1 | 7 | 570 |
GO:0005794 | Golgi apparatus | 5.21e-01 | 1.00e+00 | 0.476 | 1 | 9 | 610 |
GO:0005886 | plasma membrane | 6.09e-01 | 1.00e+00 | -0.021 | 3 | 20 | 2582 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.16e-01 | 1.00e+00 | 0.105 | 1 | 6 | 789 |
GO:0005654 | nucleoplasm | 7.35e-01 | 1.00e+00 | -0.351 | 1 | 15 | 1082 |
GO:0046872 | metal ion binding | 8.01e-01 | 1.00e+00 | -0.623 | 1 | 10 | 1307 |
GO:0006351 | transcription, DNA-templated | 8.34e-01 | 1.00e+00 | -0.769 | 1 | 6 | 1446 |